Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

Virax Biolabs Presents at H.C. Wainwright’s 24th Annual Global Investment Conference

Virax Biolabs Group Limited to Present at H.C. Wainwright’s 24th Annual Global Investment Conference in New York, NY

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Benzinga Interview: 4th of August 2022, with Chief Executive, James Foster

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders